Newly launched Seattle cancer therapy startup Callio Therapeutics raises $187M Biotech-focused investment firm Frazier Life Sciences has launched Callio Therapeutics, a cancer treatment startup with headquarters in Seattle and Singapore. Frazier led a $187 million Series A round, announced Monday,… Read More
